Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32 AI07140)
National Institutes of Health (P30 AI027757)
Received: 11 October 2021
Accepted: 29 April 2022
First Online: 13 May 2022
: The pilot study was approved by the University of Washington’s Human Subjects Division and institutional review board (STUDY00009004) and Public Health—Seattle & King County’s Research Administrative Review Committee [CitationRef removed]. All participants completed written or electronic informed consent to participate in all aspects of the study.
: Not applicable.
: Tasso, Inc. donated blood collection devices for this study. All authors have no competing financial or non-financial interests to disclose.